down arrow

ERIS Lifescience

67
Hold
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE406M01024
  • NSEID: ERIS
  • BSEID: 540596
INR
1,361.10
21.1 (1.57%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.29 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
2,009.00
1,685.00
1,347.00
1,211.00
1,074.00
982.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2,009.00
1,685.00
1,347.00
1,211.00
1,074.00
982.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
3.00
0.00
-38.00
21.00
-13.00
Raw Materials Consumed
379.00
348.00
259.00
276.00
150.00
167.00
Power & Fuel Cost
12.00
5.00
4.00
3.00
4.00
3.00
Employee Cost
403.00
346.00
250.00
229.00
205.00
190.00
Operating Expenses
23.00
13.00
7.00
7.00
10.00
5.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
178.00
158.00
101.00
108.00
123.00
118.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
134.00
102.00
85.00
91.00
73.00
4.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,334.00
1,148.00
862.00
781.00
705.00
637.00
Operating Profit (PBDIT) excl Other Income
674.00
536.00
485.00
430.00
368.00
345.00
Other Income
23.00
11.00
26.00
8.00
15.00
31.00
Operating Profit (PBDIT)
698.00
547.00
511.00
439.00
383.00
376.00
Interest
84.00
26.00
4.00
1.00
2.00
23.00
Profit before Depriciation and Tax
613.00
521.00
506.00
437.00
381.00
353.00
Depreciation
182.00
117.00
64.00
42.00
50.00
36.00
Profit Before Taxation & Exceptional Items
431.00
404.00
442.00
394.00
331.00
317.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
431.00
404.00
442.00
394.00
331.00
317.00
Provision for Tax
34.00
30.00
36.00
39.00
34.00
26.00
Profit After Tax
397.00
374.00
405.00
355.00
296.00
291.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
2,155.00
1,873.00
1,550.00
0.00
1,133.00
846.00
Profit Available for appropriations
2,547.00
2,255.00
1,956.00
0.00
1,430.00
1,137.00
Appropriations
2,547.00
2,255.00
1,956.00
0.00
1,430.00
1,137.00
Equity Dividend (%)
0.00%
735.00%
601.00%
550.00%
287.00%
0.00%
Earnings Per Share
28.82
28.10
29.89
26.16
21.61
21.15
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 19.23% vs 25.10% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 25.73% vs 10.66% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 224.06% vs 520.24% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 6.12% vs -7.79% in Mar 2023

Compare Profit and Loss Results of ERIS Lifescience
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,009.00
10,334.00
-8,325.00
-80.56%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,009.00
10,334.00
-8,325.00
-80.56%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-94.00
94.00
100.00%
Raw Materials Consumed
379.00
3,263.00
-2,884.00
-88.38%
Power & Fuel Cost
12.00
129.00
-117.00
-90.70%
Employee Cost
403.00
2,274.00
-1,871.00
-82.28%
Operating Expenses
23.00
210.00
-187.00
-89.05%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
178.00
928.00
-750.00
-80.82%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
134.00
134.00
0.00
0.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,334.00
7,798.00
-6,464.00
-82.89%
Operating Profit (PBDIT) excl Other Income
674.00
2,536.00
-1,862.00
-73.42%
Other Income
23.00
280.00
-257.00
-91.79%
Operating Profit (PBDIT)
698.00
2,817.00
-2,119.00
-75.22%
Interest
84.00
35.00
49.00
140.00%
Profit before Depriciation and Tax
613.00
2,782.00
-2,169.00
-77.97%
Depreciation
182.00
398.00
-216.00
-54.27%
Profit Before Taxation & Exceptional Items
431.00
2,384.00
-1,953.00
-81.92%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
431.00
2,399.00
-1,968.00
-82.03%
Provision for Tax
34.00
457.00
-423.00
-92.56%
Profit After Tax
397.00
1,926.00
-1,529.00
-79.39%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2,155.00
8,012.00
-5,857.00
-73.10%
Profit Available for appropriations
2,547.00
9,925.00
-7,378.00
-74.34%
Appropriations
2,547.00
9,925.00
-7,378.00
-74.34%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
28.82
47.75
-18.93
-39.64%
Profit And Loss - Net Sales
Net Sales 2,009.14 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 19.23% vs 25.10% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 674.83 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 25.73% vs 10.66% in Mar 2023

Profit And Loss - Interest
Interest 84.80 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 224.06% vs 520.24% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 397.05 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 6.12% vs -7.79% in Mar 2023